Research Article

Comparison of Low-Dose Naloxone with Ondansetron for Prevention of Sufentanil-Postoperative/Postdischarge Nausea and Vomiting

Abstract

Background: Sufentanil is extensively used as a powerful painkiller for both initiating and sustaining general anesthesia, thanks to its advantages like potent prolonged action, analgesic effect, and hemodynamic stability. Nonetheless, it's important to consider sufentanil's negative side effects, such as postoperative nausea and vomiting (PONV), during the surgical period. Additionally, Naloxone, an antagonist for opioid receptors, is frequently utilized to counteract the lingering effects of opioids after surgery. Hence, we examined the preventative use of low-dose naloxone on PONV and studied its potential mechanism of action.
Methods: After ethical approval and receiving IRCT code, 64 patients were evenly assigned to the naloxone and ondansetron groups prior to surgery. We also monitored the occurrence and intensity of PONV and the use of antiemetic medication within the first 24 hours after surgery. The main focus of our study was to analyze the PONV profile.
Results: The mean age was 49.8±15.5 years, the mean weight 71.8±23 kg, and the mean BMI was 23.5±5.2 kg/m2. No significant difference was detected regarding mean oxygen saturation and arterial pressure between the groups at admission, 15, 30, 60, and 90 min after surgery (p> 0.05). Adverse reactions showed no significant difference during the recovery time between the groups (p> 0.05). The PONV severity and incidence are significantly higher in the naloxone group.
Conclusion: Naloxone can be used as an antiemetic medicine, besides the ondansetron, and using this agent individually cannot prevent nausea and vomiting effectively.

[1] Meijer F, Cornelissen P, Sie C, Wagemans M, Mars A, Hobma T, et al. Sublingual sufentanil for postoperative pain relief: first clinical experiences. J Pain Res. 2018; 24(11):987-992.
[2] van de Donk T, Ward S, Langford R, Dahan A. Pharmacokinetics and pharmacodynamics of sublingual sufentanil for postoperative pain management. Anaesthesia. 2018; 73(2):231-237.
[3] Miao F, Feng K, Feng X, Fan L, Lang Y, Duan Q, et al. The Analgesic Effect of Different Concentrations of Epidural Ropivacaine Alone or Combined with Sufentanil in Patients After Cesarean Section. Front Pharmacol. 2021; 12:631897.
[4] Liu FL, Cherng YG, Chen SY, Su YH, Huang SY, Lo PH, et al. Postoperative recovery after anesthesia in morbidly obese patients: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth. 2015; 62(8):907-17.
[5] Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. J Anesth. 2017; 31(4):617-626.
[6] Hirmanpour A, Talakoub R, Mohammad-Salehi N, Taghian, M. A Comparative Study on the Effect of Intravenous Dexamethasone, Ondansetron, and Ketamine in Preventing Postoperative Shivering in Cesarean Section under General Anesthesia. Journal of Isfahan Medical School, 2017; 35(423): 310-317.
[7] Lee HM, Kil HK, Koo BN, Song MS, Park JH. Comparison of Sufentanil- and Fentanyl-based Intravenous Patient-controlled Analgesia on Postoperative Nausea and Vomiting after Laparoscopic Nephrectomy: A Prospective, Double-blind, Randomized-controlled Trial. Int J Med Sci 2020; 17(2):207-213.
[8] Massoth C, Schwellenbach J, Saadat-Gilani K, Weiss R, Pöpping D, Küllmar M, et al. Impact of opioid-free anaesthesia on postoperative nausea, vomiting and pain after gynaecological laparoscopy- A randomised controlled trial. J Clin Anesth. 2021; 75.
[9] Sharifi F, Meqbil YJ, Otte A, Gutridge AM, Blaine AT, van Rijn RM, et al. Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose. Pharm Res. 2021; 38(7):1221–34.
[10] Barrons RW, Woods JA. Low-Dose Naloxone for Prophylaxis of Postoperative Nausea and Vomiting: A Systematic Review and Meta-analysis. Pharmacotherapy. 2017; 37(5):546–54.
[11] Osborn MD, Lowery JJ, Skorput AGJ, Giuvelis D, Bilsky EJ. In vivo characterization of the opioid antagonist nalmefene in mice. Life Sci. 2010; 86(15–16):624–30.
[12] Zou Y, Ling Y, Kong G, Tang Y, Huang Q, Zhang L, et al. Effect of Tramadol Pretreatment on Sufentanil-Induced Cough. J Perianesth Nurs. 2019; 34(6):1181–6.
[13] Tian Z, Hu B, Miao M, Zhang L, Wang L, Chen B. Ketorolac tromethamine pretreatment suppresses sufentanil-induced cough during general anesthesia induction: A prospective randomized controlled trial. BMC Anesthesiol. 2020; 20(1):205.
[14] Xiong Z, Yi P, Song J, Tan M. Dezocine prevents sufentanil-induced cough during general anesthesia induction: A meta-analysis of randomised controlled trials. BMC Anesthesiol. 2020; 20(1):154.
[15] Horn CC. Why is the neurobiology of nausea and vomiting so important? Appetite. 2008; 50(2–3):430–4.
[16] Zou Y, Ling Y, Kong G, Tang Y, Huang Q, Zhang L, et al. Effect of Tramadol Pretreatment on Sufentanil-Induced Cough. J Perianesth Nurs. 2019; 34(6):1181–6.
[17] de Boer HD, Detriche O, Forget P. Opioid-related side effects: Postoperative ileus, urinary retention, nausea and vomiting, and shivering. A review of the literature. Best Pract Res Clin Anaesthesiol. 2017; 31(4):499–504.
[18] Makaryus R, Miller TE, Gan TJ. Current concepts of fluid management in enhanced recovery pathways. Br J Anaesth. 2018; 120(2):376–83.
[19] Müller-Lissner S, Bassotti G, Coffin B, Drewes AM, Breivik H, Eisenberg E, et al. Opioid-induced constipation and bowel dysfunction: A clinical guideline. Pain Medicine (United States). 2017; 18(10):1837–63.
[20] Busserolles J, Lolignier S, Kerckhove N, Bertin C, Authier N, Eschalier A. Replacement of current opioid drugs focusing on MOR-related strategies. Pharmacol Ther. 2020; 210.
[21] Nimeeliya Z, Derlin T, Kundil Alungal S, Kanjirathummoottil G. Epidural Naloxone Attenuates Fentanyl Induced PONV in Patients Undergoing Lower Limb Orthopaedic Surgeries. A Prospective Randomized Double-Blind Comparative Study. Rom J Anaesth Intensive Care. 2020; 27(1): 23-28.
[22] Koo CH, Yoon S, Kim BR, Cho YJ, Kim TK, Jeon Y, et al. Intraoperative naloxone reduces remifentanil-induced postoperative hyperalgesia but not pain: A randomized controlled trial. Br J Anaesth. 2017; 119(6):1161–8.
Files
IssueArticle in Press QRcode
SectionResearch Article(s)
Keywords
Sufentanil Naloxone Ondansetron Postoperative Nausea

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Rezvani Habibabadi M, Nazemroaya B, Soltanpoor M. Comparison of Low-Dose Naloxone with Ondansetron for Prevention of Sufentanil-Postoperative/Postdischarge Nausea and Vomiting. Arch Anesth & Crit Care. 2024;.